{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:18:22Z","timestamp":1793085502692,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.03.068","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T23:11:28Z","timestamp":1523488288000},"page":"2850-2854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ag85A-specific CD4 + T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory properties"],"prefix":"10.1016","volume":"36","author":[{"given":"Hannah J.","family":"Metcalfe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Biffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrain","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Connelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Martin","family":"Vordermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Villarreal-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.03.068_b0005","unstructured":"Krebs JR, Anderson R, Clutton-Brock T, Morrison I, Young D, Donnelly C. Bovine tuberculosis in cattle and badgers \u2013 report to the Rt Hon Dr Jack Cunningham MP. The Ministry of Agriculture FaF; 1997."},{"key":"10.1016\/j.vaccine.2018.03.068_b0010","unstructured":"Defra. The strategy for achieving officially bovine tuberculosis free status for England. In: Defra, editor. England, UK: Defra; 2014."},{"key":"10.1016\/j.vaccine.2018.03.068_b0015","unstructured":"Welsh-Government. Bovine TB eradication programme. Wales, UK: Welsh Government; 2017."},{"issue":"8","key":"10.1016\/j.vaccine.2018.03.068_b0020","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2018.03.068_b0025","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2013.11.045","article-title":"Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines","volume":"32","author":"Dean","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2018.03.068_b0030","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.20090504","article-title":"Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells","volume":"206","author":"Geiger","year":"2009","journal-title":"J Exp Med"},{"issue":"38","key":"10.1016\/j.vaccine.2018.03.068_b0035","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2016.07.055","article-title":"Protection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4(+) T cells but no increase in avidity for Ag85A","volume":"34","author":"Metcalfe","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.03.068_b0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2567.2003.01557.x","article-title":"Differential response of bovine monocyte-derived macrophages and dendritic cells to infection with Salmonella typhimurium in a low-dose model in vitro","volume":"108","author":"Norimatsu","year":"2003","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2018.03.068_b0045","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.immuni.2015.05.018","article-title":"GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells","volume":"42","author":"Helft","year":"2015","journal-title":"Immunity"},{"issue":"43","key":"10.1016\/j.vaccine.2018.03.068_b0050","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1016\/j.vaccine.2014.08.009","article-title":"Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle","volume":"32","author":"Villarreal-Ramos","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.03.068_b0055","first-page":"901","article-title":"Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis","volume":"9","author":"Cheon","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2018.03.068_b0060","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1128\/CVI.00427-13","article-title":"Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG","volume":"20","author":"Fletcher","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"50","key":"10.1016\/j.vaccine.2018.03.068_b0065","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1016\/j.vaccine.2007.10.011","article-title":"Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity","volume":"25","author":"Endsley","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.068_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2015.10.008","article-title":"M. tuberculosis T cell epitope analysis reveals paucity of antigenic variation and identifies rare variable TB antigens","author":"Coscolla","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.vaccine.2018.03.068_b0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.it.2015.12.009","article-title":"Reprogramming the T cell response to tuberculosis","volume":"37","author":"Woodworth","year":"2016","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.03.068_b0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3048","article-title":"The balance between protective and pathogenic immune responses in the TB-infected lung","volume":"16","author":"Orme","year":"2015","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.03.068_b0085","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.1300283","article-title":"Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation","volume":"192","author":"Woodworth","year":"2014","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.03.068_b0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.it.2014.04.006","article-title":"Tuberculosis vaccines\u2013rethinking the current paradigm","volume":"35","author":"Andersen","year":"2014","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.03.068_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.05.012","article-title":"Antigen availability shapes T cell differentiation and function during tuberculosis","volume":"21","author":"Moguche","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.vaccine.2018.03.068_b0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1601340","article-title":"T cell-derived IL-10 impairs host resistance to mycobacterium tuberculosis infection","volume":"199","author":"Moreira-Teixeira","year":"2017","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.03.068_b0105","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/eji.201040433","article-title":"Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung","volume":"40","author":"Redford","year":"2010","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.03.068_b0110","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1128\/IAI.70.6.3026-3032.2002","article-title":"Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following mycobacterium bovis BCG vaccination against experimental bovine tuberculosis","volume":"70","author":"Vordermeier","year":"2002","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T14:29:12Z","timestamp":1534948152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18304377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":22,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X18304377"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ag85A-specific CD4+ T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory properties","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Department for Environment Food and Rural Affairs. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}